-
公开(公告)号：US20170319538A1
公开(公告)日：2017-11-09
申请号：US15660133
申请日：2017-07-26
Applicant: SANOFI
Inventor： Bernard ABRAMOVICI , Jean-Claude GAUTIER , Jean-Claude GROMENIL , Jean-Marie MARRIER
IPC: A61K31/343 , A61K47/10 , A61K9/20 , A61K9/00
CPC classification number: A61K31/343 , A61K9/0053 , A61K9/2013 , A61K9/2018 , A61K9/2031 , A61K47/10 , Y02A50/465 , Y10S514/96 , Y10S514/975
Abstract: The present invention relates to a solid pharmaceutical composition for oral administration characterized in that it comprises a benzofuran derivative with antiarrhythmic activity, or one of the pharmaceutically acceptable salts thereof, as an active principle, and a pharmaceutically acceptable nonionic hydrophilic surfactant optionally in combination with one or more pharmaceutical excipients.
-
公开(公告)号：US20160338989A1
公开(公告)日：2016-11-24
申请号：US15148134
申请日：2016-05-06
Applicant: SANOFI
Inventor： Bernard ABRAMOVICI , Jean-Claude GAUTIER , Jean-Claude GROMENIL , Jean-Marie MARRIER
IPC: A61K31/343 , A61K9/20 , A61K9/00
CPC classification number: A61K31/343 , A61K9/0053 , A61K9/2013 , A61K9/2018 , A61K9/2031 , A61K47/10 , Y02A50/465 , Y10S514/96 , Y10S514/975
Abstract: The present invention relates to a solid pharmaceutical composition for oral administration characterized in that it comprises a benzofuran derivative with antiarrhythmic activity, or one of the pharmaceutically acceptable salts thereof, as an active principle, and a pharmaceutically acceptable nonionic hydrophilic surfactant optionally in combination with one or more pharmaceutical excipients.
Abstract translation: 本发明涉及用于口服给药的固体药物组合物，其特征在于其包含具有抗心律不齐活性的苯并呋喃衍生物或其药学上可接受的盐之一作为活性成分，以及任选地与一种 或更多的药物赋形剂。
-
公开(公告)号：US20130116316A1
公开(公告)日：2013-05-09
申请号：US13682283
申请日：2012-11-20
Applicant: SANOFI
Inventor： Bernard ABRAMOVICI , Jean-Claude GAUTIER , Jean-Claude GROMENIL , Jean-Marie MARRIER
IPC: A61K47/10
CPC classification number: A61K31/343 , A61K9/0053 , A61K9/2013 , A61K9/2018 , A61K9/2031 , A61K47/10 , Y02A50/465 , Y10S514/96 , Y10S514/975
Abstract: The present invention relates to a solid pharmaceutical composition for oral administration characterized in that it comprises a benzofuran derivative with antiarrhythmic activity, or one of the pharmaceutically acceptable salts thereof, as an active principle, and a pharmaceutically acceptable nonionic hydrophilic surfactant optionally in combination with one or more pharmaceutical excipients.
Abstract translation: 本发明涉及用于口服给药的固体药物组合物，其特征在于其包含具有抗心律不齐活性的苯并呋喃衍生物或其药学上可接受的盐之一作为活性成分，以及任选地与一种 或更多的药物赋形剂。
-
-
Search Results
3
records
(took 0.011 seconds)
